Geneva Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.67M | Sell |
65,925
-465,654
| -88% | -$25.9M | 0.06% | 140 |
|
|
2017
Q1 | $28.9M | Sell |
531,579
-21,900
| -4% | -$1.19M | 0.52% | 60 |
|
|
2016
Q4 | $32.3M | Sell |
553,479
-58,164
| -10% | -$3.4M | 0.63% | 52 |
|
|
2016
Q3 | $33M | Sell |
611,643
-479,551
| -44% | -$25.9M | 0.62% | 55 |
|
|
2016
Q2 | $80.3M | Buy |
1,091,194
+115,324
| +12% | +$8.48M | 1.59% | 14 |
|
|
2016
Q1 | $62.3M | Buy |
975,870
+448,853
| +85% | +$28.7M | 1.25% | 23 |
|
|
2015
Q4 | $36.3M | Buy |
527,017
+54,248
| +11% | +$3.73M | 0.7% | 52 |
|
|
2015
Q3 | $28M | Sell |
472,769
-14,112
| -3% | -$835K | 0.56% | 57 |
|
|
2015
Q2 | $32.4M | Buy |
486,881
+10,961
| +2% | +$729K | 0.58% | 59 |
|
|
2015
Q1 | $30.7M | Buy |
475,920
+443,210
| +1,355% | +$28.6M | 0.56% | 61 |
|
|
2014
Q4 | $1.93M | Sell |
32,710
-878
| -3% | -$51.8K | 0.04% | 203 |
|
|
2014
Q3 | $1.72M | Buy |
33,588
+957
| +3% | +$49K | 0.03% | 210 |
|
|
2014
Q2 | $1.58M | Buy |
32,631
+3,091
| +10% | +$150K | 0.03% | 237 |
|
|
2014
Q1 | $1.54M | Buy |
29,540
+221
| +0.8% | +$11.5K | 0.03% | 236 |
|
|
2013
Q4 | $1.56M | Buy |
29,319
+645
| +2% | +$34.3K | 0.03% | 195 |
|
|
2013
Q3 | $1.33M | Buy |
28,674
+2,251
| +9% | +$104K | 0.03% | 216 |
|
|
2013
Q2 | $1.18M | Buy |
+26,423
| New | +$1.18M | 0.03% | 202 |
|